MetaCap

Alpha Teknova Statistics

NASDAQ: TKNOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

7.63-0.18 (-2.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Alpha Teknova by the numbers

Alpha Teknova has a market capitalization of $480.0 million based on 62.90M shares outstanding. With trailing EPS of $-0.30, Alpha Teknova is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.9% below its 50-day average and 45.2% above its 200-day average.

Average daily trading volume is 437.31K shares, or about $3.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TKNO valuation vs. peer median

TKNO compared with the median of 8 peer companies
MetricTKNOPeer medianDifference
Market cap$479.95M$122.50M+292%
Avg. volume437.31K821.95K-47%

Peer median across 8 companies: MYGN, QDEL, QUIT, NNNN, ICCC, IMDX, VNRX, TRIB.

Valuation

Market cap
$479.95M
Price / sales (latest FY)
11.84
EPS (TTM)
$-0.30

Price and trading

Previous close
7.81
Open
7.63
Day range
7.52 – 7.80
52-week range
1.91 – 9.48
52-week change
+77.44%
Beta
—
Volume
254.65K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
479.95M
Forward Pe
-54.50
Eps
-0.30
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
9.48
Week52 Low
1.91
Avg Volume
437.31K
Shares Outstanding
62.90M
Ma50
7.94
Ma200
5.26
Earnings Date
Nov 4, 2026
Pct From52w High
-19.51%
Pct From52w Low
299.48%

Related